Aerovance Raises $38 Million; Plans To Partner Phase IIb Asthma Drug In 2010
This article was originally published in The Pink Sheet Daily
Executive Summary
Financing will fund Phase IIb studies and formula enhancements for uncontrolled asthma compound; expects to partner drug in 2010.